# Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

> **NCT02472652** · PHASE4 · TERMINATED · sponsor: **Gazda, Thomas D., M.D., PC** · enrollment: 2 (actual)

## Conditions studied

- Sexual Dysfunction

## Interventions

- **DRUG:** Abilify Maintena

## Key facts

- **NCT ID:** NCT02472652
- **Lead sponsor:** Gazda, Thomas D., M.D., PC
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06
- **Primary completion:** 2016-12-31
- **Final completion:** 2017-03-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Lack of adequate enrollment
- **Last updated:** 2019-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02472652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02472652, "Aripiprazole, Abilify Maintena Collaborative Clinical Protocol". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02472652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*